AGP Executive Report
Last update: an hour agoEuropean Market: Cronos completed its €57.5 million acquisition of CanAdelaar, the Netherlands’ largest adult-use cannabis operator, giving the Canadian company a foothold in Europe’s biggest regulated adult-use market. CBD Research: Lexaria says a new animal study found improved blood absorption from one CBD formulation; the company has filed three related patent applications, but has not released full results. Global Medical Cannabis: MediPharm Labs shipped its first CBD metered-dose inhaler to Panama, extending its international reach. A Moroccan pharmaceutical company also unveiled what it called the country’s first locally produced medical cannabis drug. Clinical Caution: A review found limited benefit from medical cannabis for insomnia compared with placebo, underscoring that promising products still need strong clinical support.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.